Valeant accused of ‘aggressive accounting games’ by renowned short-seller Jim Chanos
Nicolas Van Praet, 16 May 2014
Valeant Pharmaceuticals International Inc. teamed up with respected activist Bill Ackman to buy Allergan Inc. in part to build its own legitimacy with investors after several periods of short-selling in Valeant stock in recent years. So far, however, the partnership has done little to silence the most vocal voices betting against Canada’s largest drug company. Continue reading “Article: Valeant accused of ‘aggressive accounting games’ by renowned short-seller Jim Chanos”

Steve Cohen – “The Hedge Fund King”
S2014 E1: To Catch a Trader